prader willi glp 1 agonist Novel therapeutics in rare genetic obesities: A narrative review Do GLP-1 medications work the

This enables weekly dosing , the same regimen as Semaglutide, parallel clinical convenience

ANZ J Surg

(5) Yu-Xiang Kong, Zhi-Shuai Li, Yuan-Bo Liu, Bo Pan, et al (2025) FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation Communications Biology, volume 8, Article number: 299 (2025)

The insufficient in vivo studies on semaglutide and limited in vitro research raise concerns about the imperative for more comprehensive investigations into its effects

Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms